WASHINGTON, Dec. 27, 2022 /PRNewswire/ — GoodFirms, the globally renowned research, ratings, and reviews platform, recently announced the latest list of the best task management software. The identified task management platforms make it easy for organizations to prioritize tasks, share updates, and organize and manage everything from a single dashboard.
Best Task Management Software at GoodFirms:
TaskQue, Intervals, Beesbusy, Flowlu, TaskOnBOt, Trello, Todoist, Asana, monday.com, Smartsheet.
Businesses often face the challenge of managing multiple projects and the tasks to accomplish. Factors like time, budget, resources, man-management, communication, etc., require stringent monitoring to complete the project successfully. So today, most companies are taking advantage of task management software to perform projects in a well-organized manner and effectively.
Task management software allows individuals to log into a task management dashboard to have flexible working hours for employees working from home or on the go. It also allows managers and teams to achieve deadlines, track the time of specific tasks, set priorities, track progress, attend meetings, allocate resources appropriately, and optimize all projects effectively.
"Task management software integrates automation for recurring tasks, and also generates reports that help in tracking the performance and gain useful insights."
Key features of the best task management tool include collaboration tools, document management, portfolio management, progress tracking, project budgeting, project planning, project scheduling, reporting, task management, team collaboration, resource management and time tracking. Service seekers can choose task management software that covers all the features and obtain additional benefits for optimizing the workflow and improving productivity.
With this year-end listing, GoodFirms aims to assist service seekers in choosing the perfect task management software that helps organizations to create a better work-life balance and enhance productivity in the coming years. Organizations can also take advantage of the advanced filter options for features, pricing models, devices supported, deployment, business size, etc. Furthermore, they can also verify the most reviewed, top-rated tools and select the suitable system.
Here at GoodFirms, businesses can also find a list of various tools for specific requirements like document management software, project planning software, time tracking software, employee engagement software, collaboration software, appointment scheduling software, and reporting software.
Best Document Management Software:
eFileCabinet, OnlyOffice, KRYSTAL DMS, Dokmee, dMACQ DMS, Zoho Docs, Alfresco Content Services, OpenKM, M-Files, DocuWare.
Best Project Planning Software:
Magic Projects, Taiga, Evernote, Zoho Projects, Wrike, Teamwork Projects, Celoxis, Freedcamp, Toggl Plan, LiquidPlanner.
Best Time Tracking Software:
TMetric, WebWorker Time Tracker, Trackabi, TaskBlast, Eddy, Time Doctor, QuickBooks Time, Replicon, TimeCamp, Clockify.
Best Collaboration Software:
Troop Messenger, Microsoft 365, Basecamp, Zoho projects, Airtable, Miro, Notion, Webex, GoToMeeting, Google Workspace.
Best Reporting Software:
Whatagraph, datapine, Tableau, Zoho Analytics, Zoho Projects, Teamwork Projects, Bitrix24, iVisit, QuickBooks Commerce, ActiveCollab.
GoodFirms follows a strict methodology to conduct thorough research based on quality, reliability, and ability to cater to the needs of service seekers. The task management software list was created based on several parameters such as the background of each product, the company, years of experience in the domain areas, online market penetration, client feedback, and much more. Only those companies that attained the maximum score made it to the list.
If you are a task management software service provider and wish to get listed, you can partake in the GoodFirms research processes. Interestingly, gaining the top position among the best service providers will attract the attention of potential prospects, increase productivity, help generate more sales, and earn more profit.
About GoodFirms:
GoodFirms is a Washington, D.C.-based B2B research firm specializing in identifying the most prominent and efficient IT companies and software providers that can automate the tasks of various industries. GoodFirms' industry-wide research, review & rankings help service seekers leap further and multiply their industry-wide value and credibility.
Contact: Sophia Jayden (sophia@goodfirms.co)
View original content to download multimedia:https://www.prnewswire.com/news-releases/goodfirms-unlocks-the-best-task-management-software-with-rich-features-301710224.html
SOURCE GoodFirms
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
By Marcelo Trevino, Agendia
Software that is qualified as an in vitro diagnostic medical device (known as SaMD IVD) is affected by the same requirements as other medical devices, which are governed by various FDA regulations and EU In Vitro Diagnostic (IVD) Regulation EU 2017/746. Therefore, SaMD IVD's intended use, classification, clinical/performance requirements, and the content of the technical documentation must comply with these regulations. In my last article, I described how to know if FDA and EU regulators qualify your software as an IVD SaMD. This article builds on that foundation and summarizes the regulatory framework required for IVD SaMD in the U.S. and European markets.
In the U.S., IVD SaMD is classified according to risk-based criteria based on the intended use, then software is categorized by level of concern to establish the evidence required. There are four steps involved in the classification:
1. Select the appropriate device type regulation: There are three sections of regulations that cover IVD devices: 21 CFR Part 862 Clinical Chemistry and Clinical Toxicology, 21 CFR Part 864 Hematology and Pathology, and 21 CFR Part 866 Immunology and Microbiology.
2. Determine the appropriate device risk classification: There are three levels: Class I (low to moderate risk, general controls required), Class II (moderate to high risk, general controls and special controls required), or Class III (highest risk, general controls and premarket approval required).
3. Review device classification exceptions: Depending on the applicable regulations associated with the device, some devices might be exempt from premarket notification requirements.
4. Determine the associated product codes: Based on the applicable regulation number, FDA’s product classification database shall be used to review available product codes to identify predicate devices and the substantial equivalence information.
The “level of concern” refers to an estimate of the severity of injury that a device could permit or inflict, either directly or indirectly, on a patient or operator as a result of device failures, design flaws, or simply by virtue of employing the device for its intended use. There are three levels of concern for device software in the U.S.: major, moderate, and minor. To establish the level of concern, manufacturers should answer questions provided in FDA’s Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices and establish a rationale. This will determine the amount of documentation required in the premarket submission. FDA considers IVD software to be at least a moderate level of concern because software flaws could indirectly affect a patient and could potentially result in injury.
After the software is qualified as an IVD, the manufacturer shall define its intended use, since the intended use determines the regulatory classification of the software. The intended use shall capture the software’s core functionality and the effect of the information provided for healthcare decisions.
Once the software is qualified as an in vitro diagnostic medical device, the next step is to determine its risk class based on Annex VIII of Regulation (EU) 2017/746.
Rule 1.4 of Annex VIII indicates: “Software, which drives a device or influences the use of a device, shall fall within the same class as the device; If the software is independent of any other device, it shall be classified in its own right.”
Rule 1.8 of Annex VIII indicates: “Where a manufacturer states multiple intended purposes for a device, and as a result the device falls into more than one class, it shall be classified in the higher class.” Rule 1.9. of Annex VIII indicates: “If several classification rules apply to the same device, the rule resulting in the higher classification shall apply.”
MDCG 2019-11 provides examples of classification. However, it is important to note that these examples should not be considered confirmation of the final device’s classification, as manufacturers shall consider all the rules under Annex VIII for the in vitro diagnostic medical device software according to its intended purpose, and the justification should be documented in the device’s technical documentation.
In the EU, once a software qualifies as an in vitro diagnostic medical device, the manufacturer must demonstrate compliance with the 20 general safety and performance requirements detailed in Annex I of Regulation (EU) 2017/746. If some of these are not applicable, a justification must be provided. Software compliance can be supported through the use of different harmonized standards such as EN ISO 14971:2019 for medical device risk management.
Below are the relevant GSPRs affecting software:
GSPR 13.2(d) requires devices to be designed and manufactured in such a way as to remove or reduce as far as possible the risks associated with the possible negative interaction between software and the IT environment within which it operates and interacts.
GSPR 16 focuses on software and includes four points:
GSPR 20.4.1 (ah) addresses information required in the instructions for use and requires that the instructions for use for devices that incorporate electronic programmable systems, including software, or software that are devices in themselves, shall contain minimum requirements concerning hardware, IT network characteristics, and IT security measures, including protection against unauthorized access, necessary to run the software as intended.
Software performance must also be demonstrated. MDCG 2020-1: Guidance on Clinical Evaluation (MDR)/Performance Evaluation (IVDR) of Medical Device Software provides guidance on the level of evidence required according to the EU 2017/746 IVD Regulation.
FDA and EU IVDR regulators require clinical evidence through performance evaluation. FDA and EU recognize IMDRF/SaMD/WG/N41 Final: 2017 for demonstrating clinical evaluation of SaMD in general. In the EU, there is an additional guidance provided for IVD SaMD: MDCG-2020-1 Guidance on Clinical Evaluation (MDR)/Performance Evaluation (IVDR) of Medical Device Software.
To demonstrate that the IVD SaMD performs as intended, manufacturers shall demonstrate that the software is designed using recognized standards and also that it can achieve its medical purpose safely and effectively. If the IVD SaMD uses an algorithm that must be trained to perform as intended, manufacturers shall provide a conclusion that the algorithm works for its medical purpose as part of the analytical and clinical performance evidence. Regulatory agencies in the U.S. and the EU will expect to see a description of the data sets used to evaluate the software, including inclusion or exclusion criteria, clinical site descriptions, number of subjects, algorithm development processes, statistical models used, and performance measures for verification and validation. Any claimed benefits must be supported with clinical evidence based on performance evaluation.
A valid clinical association shall be established between the IVD SaMD output and the target clinical condition and clinical studies to evaluate analytical and clinical performance. Effective performance of the SaMD’s intended use shall be demonstrated through analytical performance (demonstration that the software processes input data to generate accurate output data, which may include analytical sensitivity, analytical specificity, bias, precision, accuracy, limits of detection, and method comparison) and clinical performance (the analytical use of the software applied to the target population in a clinical care setting achieving its stated intended purpose or claimed benefit, which can be demonstrated referencing existing data from studies performed for the same intended use or by generating new clinical data for the specific software’s intended use).
For the EU, Annexes II and III of 2017/746 IVD Regulation provide details on the technical documentation that must be gathered for the software. EN 62304 provides good guidance to ensure most requirements are adequately addressed and the documentation generated according to EN 62304 standard allows a large part of the regulatory requirements to be met. The information to be provided includes, among others: an overview of the entire system and a description of the data interpretation methodology, a summary of the results of all verification, validation, and testing applicable in a real-world usage environment, labeling information, configurations, and operating systems required.
Similarly, FDA’s draft guidance Content of Premarket Submissions for Device Software Functions and Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices provide details on the recommended documentation that software manufacturers should include in premarket submissions. This includes, for example, software description, system and software architecture diagrams, risk management file, device hazard analysis for software devices, software design specifications, software level of concern classification, and verification and validation activities, among others.
As part of the Medical Device User Fee Amendment V (MDUFA V) passed by the U.S. Congress on Sept. 30, 2022, FDA established several Digital Health Commitments to be accomplished between fiscal year 2023 and fiscal year 2027 that will continue to build its digital health expertise and work to streamline and align their review processes with software life cycles for digital health products. The following are the six Digital Health Commitments:
Conclusion
As SaMD becomes more predominant in the medical device world, it is important for manufacturers and developers to understand how to qualify an IVD SaMD and then to establish the analytical and clinical claims for the software to define its intended use, since this is how performance will be assessed by regulators to comply with regulatory requirements. IMDRF/SaMD WG/41 Final: 2017 is a thorough guidance document on how to approach performance evaluation for IVD SaMD, which is crucial to demonstrate that the IVD SaMD is safe and effective. There are many guidance documents and tools available to aid manufacturers through the IVD SaMD regulatory process, particularly driven by FDA’s CDRH Digital Health Center of Excellence, which provides digital health expertise and policy direction that manufacturers and developers should take advantage of. This is particularly important as many embark in IVD SaMD development activities that continue to evolve rapidly as artificial intelligence and machine learning applications continue growing in the medical device world.
About The Author:
Marcelo Trevino is the global vice president, regulatory affairs and quality assurance at Agendia, a molecular diagnostics company focused on breast cancer genomic testing. He has more than 20 years of experience in global regulatory affairs, quality, and compliance, serving in senior leadership roles with different medical device organizations. He has an extensive knowledge of medical device management systems and medical device regulations worldwide. Trevino holds a BS in industrial and systems engineering and an MBA in supply chain management from the W.P. Carey School of Business at ASU. He is also a certified Medical Device Master Auditor and QMS Master Auditor by Exemplar Global. He can be reached at marcelotrevino@outlook.com or on LinkedIn.
Get the latest articles from Med Device Online delivered to your inbox.
Hi, what are you looking for?
By
Published
The Latest published a market study on Global Credential Management Solutions Market provides an overview of the current market dynamics in the Credential Management Solutions space, as well as what our survey respondents— all outsourcing decision-makers— predict the market will look like in 2028. The study breaks the market by revenue and volume (wherever applicable) and price history to estimate the size and trend analysis and identify gaps and opportunities. Some of the players that are in coverage of the study are SkyXoft Technologies, Inc. (Canada), Smartsheet Inc. (United States), MedTrainer (United States), Hyland Software (United States), ideal privileges (United States), SkillSurvey (United States), NetForum (united States), Applied Statistics & Management (United States), Vistaar Technologies, Inc. (United States), IntelliSoft Group (United States).
Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/127967-global-credential-management-solutions-market#utm_source=DigitalJournal/Rahul
Scope of the Report of Credential Management Solutions
Credential management solutions are used to control access to sensitive data, organizations require user credentials. Deploying a sound credential management system—or several credential management systems—is critical to secure all systems and information. Authorities must be able to create and revoke credentials as customers and employees come and go or simply change roles, and as business processes and policies evolve. Furthermore, the rise of privacy regulations and other security mandates increases the need for organizations to demonstrate the ability to validate the identity of online consumers and internal privileged users.
The titled segments and sub-section of the market are illuminated below:
by Application (Appointment Management, Committee Management, Document Management, Online Applications, Privileging, Others), Organization Size (Small & Medium Enterprises (SMEs), Large Enterprises), Platform (Mac, IPad, Android, Linux, Others), End Use Industry (BFSI, Retail, Telecommunication, Government/Public Sector, Healthcare, Real Estate, Energy and Power, Manufacturing, Others), Deployment (Cloud-Based, On-Premises), Pricing Type (Monthly Subscription, Annual Subscription, One-Time License)
Market Trends:
Tamper-Evident and Intrusion-Resistant HSMs Provide the Highest Level of Physical Security
Opportunities:
Demand for Credential Management Solutions for Data Security in the Cloud Environment
Achieve Point-To-Point Encryption by Complying With PCI Standards
Market Drivers:
Growing Number of Data Breaches and Cyberattacks across the World
Effective Management of Cryptographic Keys
Stringent Government Regulations for Security and Privacy of Data
What can be explored with the Credential Management Solutions Market Study?
o Track Right Markets
o Identify the Right Verticals
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
Have Any Questions Regarding Global Credential Management Solutions Market Report, Ask Our [email protected] https://www.advancemarketanalytics.com/enquiry-before-buy/127967-global-credential-management-solutions-market#utm_source=DigitalJournal/Rahul
Strategic Points Covered in Table of Content of Global Credential Management Solutions Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Credential Management Solutions market
Chapter 2: Exclusive Summary – the basic information of the Credential Management Solutions Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Credential Management Solutions
Chapter 4: Presenting the Credential Management Solutions Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020
Chapter 6: Evaluating the leading manufacturers of the Credential Management Solutions market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2027)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
finally, Credential Management Solutions Market is a valuable source of guidance for individuals and companies.
Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/127967-global-credential-management-solutions-market#utm_source=DigitalJournal/Rahul
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.
Contact US:
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (551) 333 1547
[email protected]
Connect with us at
https://www.linkedin.com/company/advance-market-analytics
https://www.facebook.com/AMA-Research-Media-LLP-344722399585916
https://twitter.com/amareport
Botanists used a variety of tools to identify breadfruit lineages growing in the Caribbean today.
Denise Coates founded Bet365 in the early 2000s before turning into a global powerhouse of the online gaming world – Copyright AFP Indranil MUKHERJEE…
A dozen Ukrainian startups proudly showed off innovations at CES on Friday.
At the CES technology show in Las Vegas, boat builders are putting a big focus on technologies and artificial intelligence.
COPYRIGHT © 1998 – 2023 DIGITAL JOURNAL INC. Sitemaps: XML / News . Digital Journal is not responsible for the content of external sites. Read more about our external linking.
